๐ฅ๐ฒ๐ฆ๐๐ป๐ฎ๐ฝ๐๐ฒ ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ฒ๐๐๐ถ๐ฐ๐: ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐ก๐ฒ๐๐ฟ๐ผ๐ฝ๐๐๐ฐ๐ต๐ถ๐ฎ๐๐ฟ๐ ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐ ๐๐น๐๐ถ-๐ง๐ฎ๐ฟ๐ด๐ฒ๐ ๐๐ฟ๐๐ด ๐๐ฒ๐๐ถ๐ด๐ป ๐ฃ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ ๐ณ๐ผ๐ฟ ๐ฆ๐ฒ๐ฟ๐ผ๐๐ผ๐ป๐ถ๐ป ๐ ๐ผ๐ฑ๐๐น๐ฎ๐๐ถ๐ผ๐ป
We're developing multi-target compounds for serotonin modulation to create fast-acting, long-lasting treatments for depression. Our approach:
โข Targets specific multi-CNS receptors simultaneously
โข Aims to overcome limitations of SSRIs and psychedelic-derived treatments
โข Utilizes advanced computational chemistry drug design platform
Recent achievements:
โข Non-dilutive grant awarded for our novel "recipe" platform
โข Positive KOL evaluation of feasibility and validation
Seeking seed funding for POC development and strategic partnerships to advance our mission.
ReSynapse Therapeutics is developing the first systematic multi-target platform for precision neuropsychiatry, addressing the treatment-resistant depression crisis where current therapies fail 83.3% of patients. Using advanced computational chemistry, the company designs novel drugs that target specific receptor combinations with precise modulation modes, like programming an electronic key code, aiming to deliver a 1-2 week onset versus the 4-6 weeks required by traditional antidepressants. Led by serial entrepreneurs with $7M in prior exits and a Skolnik Prize-winning computational chemistry leader. The platform approach creates a scalable moat, positioning between failed single-target drugs and risky psychedelics to capture the 2.8 million Americans and 11 million Europeans suffering from treatment-resistant depression, with only 16.7% remission rates under current care.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://resynapse.carrd.co/
Resynapse Therapeutics Questions
Resynapse Therapeutics's website is https://resynapse.carrd.co/
Resynapse Therapeutics's LinkedIn profile is https://www.linkedin.com/company/resynapse-therapeutics
Resynapse Therapeutics's industry is
Biotechnology Research
Resynapse Therapeutics's top competitors are
Publlo,
Blue-Premium,
Wonderful Ai,
Iaso Ventures,
Lario Therapeutics,
Akasi Pharma,
Occamzrazor,
4th European Congress Of Neurology And Neuropsychiatry,
Kesmalea Therapeutics,
Sleek.
Resynapse Therapeutics's categories are Biotechnology Research
